Cytek Biosciences reports 2022 annual meeting voting results; Class I directors elected and auditor ratified

Cytek Biosciences, Inc.

Deborah Neff and Don Hardison elected as Class I directors with ~88.7M and ~88.7M votes for, respectively.
Ratification of Deloitte & Touche as auditor for FY2022 approved with 115.4M votes for, 5,450 against.
Approximately 86% of outstanding shares (116M out of 134.2M) represented at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.